296 related articles for article (PubMed ID: 22637696)
1. In situ validation of an intestinal stem cell signature in colorectal cancer.
Ziskin JL; Dunlap D; Yaylaoglu M; Fodor IK; Forrest WF; Patel R; Ge N; Hutchins GG; Pine JK; Quirke P; Koeppen H; Jubb AM
Gut; 2013 Jul; 62(7):1012-23. PubMed ID: 22637696
[TBL] [Abstract][Full Text] [Related]
2. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
Stange DE; Engel F; Longerich T; Koo BK; Koch M; Delhomme N; Aigner M; Toedt G; Schirmacher P; Lichter P; Weitz J; Radlwimmer B
Gut; 2010 Sep; 59(9):1236-44. PubMed ID: 20479215
[TBL] [Abstract][Full Text] [Related]
3. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.
Takeda K; Kinoshita I; Shimizu Y; Matsuno Y; Shichinohe T; Dosaka-Akita H
Anticancer Res; 2011 Jan; 31(1):263-70. PubMed ID: 21273608
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
[TBL] [Abstract][Full Text] [Related]
5. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
6. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
7. Logarithmic expansion of LGR5
Martin ML; Zeng Z; Adileh M; Jacobo A; Li C; Vakiani E; Hua G; Zhang L; Haimovitz-Friedman A; Fuks Z; Kolesnick R; Paty PB
Cell Signal; 2018 Jan; 42():97-105. PubMed ID: 28958617
[TBL] [Abstract][Full Text] [Related]
8. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia.
Jubb AM; Chalasani S; Frantz GD; Smits R; Grabsch HI; Kavi V; Maughan NJ; Hillan KJ; Quirke P; Koeppen H
Oncogene; 2006 Jun; 25(24):3445-57. PubMed ID: 16568095
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy.
Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Uchida K; Mohri Y; Kusunoki M
Int J Oncol; 2012 Nov; 41(5):1643-52. PubMed ID: 22923071
[TBL] [Abstract][Full Text] [Related]
10. Identification of stem cells in small intestine and colon by marker gene Lgr5.
Barker N; van Es JH; Kuipers J; Kujala P; van den Born M; Cozijnsen M; Haegebarth A; Korving J; Begthel H; Peters PJ; Clevers H
Nature; 2007 Oct; 449(7165):1003-7. PubMed ID: 17934449
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor achaete scute-like 2 controls intestinal stem cell fate.
van der Flier LG; van Gijn ME; Hatzis P; Kujala P; Haegebarth A; Stange DE; Begthel H; van den Born M; Guryev V; Oving I; van Es JH; Barker N; Peters PJ; van de Wetering M; Clevers H
Cell; 2009 Mar; 136(5):903-12. PubMed ID: 19269367
[TBL] [Abstract][Full Text] [Related]
12. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
13. Myb controls intestinal stem cell genes and self-renewal.
Cheasley D; Pereira L; Lightowler S; Vincan E; Malaterre J; Ramsay RG
Stem Cells; 2011 Dec; 29(12):2042-50. PubMed ID: 21997934
[TBL] [Abstract][Full Text] [Related]
14. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
[TBL] [Abstract][Full Text] [Related]
15. Identification of cells expressing OLFM4 and LGR5 mRNA by in situ hybridization in the yolk sac and small intestine of embryonic and early post-hatch chicks.
Zhang H; Wong EA
Poult Sci; 2018 Feb; 97(2):628-633. PubMed ID: 29155957
[TBL] [Abstract][Full Text] [Related]
16. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
17. Expansion of intestinal epithelial stem cells during murine development.
Dehmer JJ; Garrison AP; Speck KE; Dekaney CM; Van Landeghem L; Sun X; Henning SJ; Helmrath MA
PLoS One; 2011; 6(11):e27070. PubMed ID: 22102874
[TBL] [Abstract][Full Text] [Related]
18. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
19. Induction of LGR5 by H2O2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells.
Kim SH; Kim KH; Yoo BC; Ku JL
Int J Oncol; 2012 Nov; 41(5):1744-50. PubMed ID: 22923033
[TBL] [Abstract][Full Text] [Related]
20. Distribution of intestinal stem cell markers in colorectal precancerous lesions.
Jang BG; Kim HS; Kim KJ; Rhee YY; Kim WH; Kang GH
Histopathology; 2016 Mar; 68(4):567-77. PubMed ID: 26212207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]